Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway
Authors:
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 50, 131-141
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572280, 81502121, 81401548)
- Natural Science Foundation of Hunan Province (2018JJ3787)
- Central South University (JY2015011)
This publication has 52 references indexed in Scilit:
- Integrin signaling in control of tumor growth and progressionThe International Journal of Biochemistry & Cell Biology, 2013
- Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic modelOncogene, 2012
- Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in miceProceedings of the National Academy of Sciences, 2010
- Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer ProgressionCancer Cell, 2009
- Focal adhesion kinase: in command and control of cell motilityNature Reviews Molecular Cell Biology, 2005
- Cysteine cathepsins in human cancerBiological Chemistry, 2004
- Up‐regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasiaThe Prostate, 2004
- FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassemblyNature Cell Biology, 2004
- Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrestEuropean Journal of Cancer, 2002
- Expression of pp60c-src in human small cell and non-small cell lung carcinomasEuropean Journal of Cancer, 1992